PYXS
Pyxis Oncology Inc
NASDAQ: PYXS · HEALTHCARE · BIOTECHNOLOGY
$1.70
+2.41% today
Updated 2026-04-30
Market cap
$106.81M
P/E ratio
—
P/S ratio
7.71x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$1 – $6
Volume
0.4M
Pyxis Oncology Inc (PYXS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-6.3%
Last 4 quarters
Revenue YoY growth
+224.5%
Most recent quarter
EPS YoY growth
+78.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.9%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+9.6%
2025-11-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-25 | $-0.29 | +11.8% | $1.36 | $1.39 | +2.2% |
| 2025-11-03 | $-0.35 | -2.9% | $3.56 | $3.90 | +9.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.33 | $-0.29 | +11.8% | $11.04M | +224.5% |
| 2025-09-30 | $-0.34 | $-0.35 | -2.9% | — | — |
| 2025-06-30 | $-0.34 | $-0.30 | +11.8% | $2.82M | — |
| 2025-03-31 | $-0.24 | $-0.35 | -45.8% | — | — |
| 2024-12-31 | $-0.32 | $-1.32 | -312.5% | $3.40M | -0.5% |
| 2024-09-30 | $-0.32 | $-0.35 | -9.4% | — | — |
| 2024-06-30 | $-0.32 | $-0.29 | +9.4% | — | — |
| 2024-03-31 | $-0.24 | $-0.06 | +75.0% | $16.15M | — |
| 2023-12-31 | $-0.47 | $-0.33 | +29.8% | $3.42M | — |
| 2023-09-30 | $-0.51 | $-0.56 | -9.8% | — | — |
| 2023-06-30 | $-0.65 | $-0.41 | +36.9% | — | — |
| 2023-03-31 | $-0.90 | $-0.55 | +38.9% | — | — |
Frequently asked questions
Has Pyxis Oncology Inc beaten earnings estimates?
Pyxis Oncology Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -6.3% over the last 4 quarters.
How does PYXS stock react to earnings?
PYXS stock has moved an average of +5.9% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Pyxis Oncology Inc's revenue growth rate?
Pyxis Oncology Inc reported year-over-year revenue growth of +224.5% in its most recent quarter, with EPS growing +78.0% year-over-year.